Literature DB >> 32635349

Characteristics of Adverse Events Following Immunization Reporting in Children: The Japanese Adverse Drug Event Report Database.

Aoi Noda1,2,3, Takamasa Sakai4, Masami Tsuchiya5,6, Gen Oyanagi3, Taku Obara1,2,3, Nariyasu Mano3,5.   

Abstract

The present study aimed to describe the trends and characteristics of adverse events following immunization (AEFI) reporting for children in the Japanese Adverse Drug Event Report database (JADER). We used 6280 AEFI reports for children aged <19 years among 504,407 ADR reports included in the JADER from 2004 to 2017. The number of AEFI reports gradually increased among children aged <10 years and was the highest in 2011 among children aged 10-19 years. The number of suspected vaccines per AEFI report increased after 2011 among children aged <10 years. The percentage of "death" and "did not recover" as AEFI outcomes reported were 4.3% and 3.7% among children aged <10 years and 0.2% and 21.1% among children aged 10-19 years, respectively. The most frequently reported vaccine-reaction pair was Haemophilus influenzae type b conjugate vaccine and pyrexia among children aged <10 years and recombinant adsorbed bivalent human papillomavirus-like particle vaccine and a loss of consciousness among children aged 10-19 years. It is necessary to consider the Weber effects to understand the trend and characteristics of AEFI reporting because pharmacovigilance activity regarding vaccination is not sufficient in Japan.

Entities:  

Keywords:  adverse events following immunization; children; spontaneous reports; vaccine

Year:  2020        PMID: 32635349     DOI: 10.3390/vaccines8030357

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  2 in total

1.  Time-Dependent Changes in Death Reports and the Sex Ratio in the Safety Surveillance of SARS-CoV-2 Vaccination in Japan, the United States, and European Countries.

Authors:  Erika Yamashita; Morihito Takita; Masahiro Kami
Journal:  Cureus       Date:  2022-03-22

2.  Adverse Drug Reaction Reports Regarding Abnormal Behavior After Oseltamivir Use in Children as Reported by Consumers or Healthcare Professionals.

Authors:  Aoi Noda; Masami Tsuchiya; Takamasa Sakai; Taku Obara; Nariyasu Mano
Journal:  Patient Prefer Adherence       Date:  2021-03-04       Impact factor: 2.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.